JB Chemicals & Pharmaceuticals Limited
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage … Read more
Market Cap & Net Worth: JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
JB Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) has a market capitalization of $3.90 Billion (₹337.75 Billion) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #5071 globally and #172 in its home market, demonstrating a 1.56% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying JB Chemicals & Pharmaceuticals Limited's stock price ₹2104.00 by its total outstanding shares 160527546 (160.53 Million).
JB Chemicals & Pharmaceuticals Limited Market Cap History: 2015 to 2026
JB Chemicals & Pharmaceuticals Limited's market capitalization history from 2015 to 2026. Data shows growth from $231.49 Million to $3.90 Billion (30.32% CAGR).
Index Memberships
JB Chemicals & Pharmaceuticals Limited is a constituent of 6 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY PHARMA
CNXPHARMA
|
$57.59 Billion | 3.35% | #12 of 20 |
|
NIFTY 500
NIFTY500
|
$1.27 Trillion | 0.15% | #159 of 500 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$535.73 Billion | 0.36% | #85 of 400 |
|
NIFTY MNC
NIFTYMNC
|
$121.75 Billion | 1.59% | #12 of 30 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$1.32 Trillion | 0.15% | #159 of 750 |
|
NIFTY SMALLCAP 250
NISM250
|
$188.65 Billion | 1.02% | #13 of 250 |
Weight: JB Chemicals & Pharmaceuticals Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
JB Chemicals & Pharmaceuticals Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how JB Chemicals & Pharmaceuticals Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.09x
JB Chemicals & Pharmaceuticals Limited's market cap is 0.09 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.51x
JB Chemicals & Pharmaceuticals Limited's market cap is 0.51 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $298.62 Million | $11.68 Billion | $1.62 Billion | 0.03x | 0.18x |
| 2017 | $288.62 Million | $13.10 Billion | $1.84 Billion | 0.02x | 0.16x |
| 2018 | $261.26 Million | $13.85 Billion | $1.38 Billion | 0.02x | 0.19x |
| 2019 | $369.43 Million | $16.10 Billion | $1.93 Billion | 0.02x | 0.19x |
| 2020 | $903.46 Million | $17.43 Billion | $2.72 Billion | 0.05x | 0.33x |
| 2021 | $1.59 Billion | $20.06 Billion | $4.48 Billion | 0.08x | 0.36x |
| 2022 | $1.75 Billion | $24.24 Billion | $3.85 Billion | 0.07x | 0.45x |
| 2023 | $2.98 Billion | $31.17 Billion | $4.10 Billion | 0.10x | 0.73x |
| 2024 | $3.42 Billion | $34.84 Billion | $5.53 Billion | 0.10x | 0.62x |
| 2025 | $3.37 Billion | $39.18 Billion | $6.60 Billion | 0.09x | 0.51x |
Competitor Companies of JBCHEPHARM by Market Capitalization
Companies near JB Chemicals & Pharmaceuticals Limited in the global market cap rankings as of March 18, 2026.
Key companies related to JB Chemicals & Pharmaceuticals Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
JB Chemicals & Pharmaceuticals Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, JB Chemicals & Pharmaceuticals Limited's market cap moved from $231.49 Million to $ 3.90 Billion, with a yearly change of 30.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹3.90 Billion | +15.62% |
| 2025 | ₹3.37 Billion | -1.33% |
| 2024 | ₹3.42 Billion | +14.63% |
| 2023 | ₹2.98 Billion | +70.21% |
| 2022 | ₹1.75 Billion | +9.90% |
| 2021 | ₹1.59 Billion | +76.45% |
| 2020 | ₹903.46 Million | +144.56% |
| 2019 | ₹369.43 Million | +41.40% |
| 2018 | ₹261.26 Million | -9.48% |
| 2017 | ₹288.62 Million | -3.35% |
| 2016 | ₹298.62 Million | +29.00% |
| 2015 | ₹231.49 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of JB Chemicals & Pharmaceuticals Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.90 Billion USD |
| MoneyControl | $3.90 Billion USD |
| MarketWatch | $3.90 Billion USD |
| marketcap.company | $3.90 Billion USD |
| Reuters | $3.90 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.